Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Operating Leases (2020 - 2025)

Historic Operating Leases for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to $27.4 million.

  • PROCEPT BioRobotics' Operating Leases fell 630.14% to $27.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.4 million, marking a year-over-year decrease of 630.14%. This contributed to the annual value of $26.9 million for FY2024, which is 262.01% up from last year.
  • Latest data reveals that PROCEPT BioRobotics reported Operating Leases of $27.4 million as of Q3 2025, which was down 630.14% from $27.8 million recorded in Q2 2025.
  • In the past 5 years, PROCEPT BioRobotics' Operating Leases registered a high of $49.2 million during Q4 2021, and its lowest value of $3.1 million during Q2 2022.
  • Moreover, its 5-year median value for Operating Leases was $27.8 million (2025), whereas its average is $24.8 million.
  • As far as peak fluctuations go, PROCEPT BioRobotics' Operating Leases skyrocketed by 110117.19% in 2021, and later plummeted by 5386.18% in 2022.
  • Over the past 5 years, PROCEPT BioRobotics' Operating Leases (Quarter) stood at $49.2 million in 2021, then plummeted by 53.86% to $22.7 million in 2022, then increased by 15.34% to $26.2 million in 2023, then rose by 2.62% to $26.9 million in 2024, then grew by 1.83% to $27.4 million in 2025.
  • Its Operating Leases stands at $27.4 million for Q3 2025, versus $27.8 million for Q2 2025 and $28.3 million for Q1 2025.